0.2408

5.46% -0.0139

AEON Biopharma Inc. (AEON)

Overview News Price History Discussions Forecast

AEON Biopharma Inc. stock is traded at $0.2408, with a volume of 758.58K. It is down -5.46% in the last 24 hours and down -18.65% over the past month. AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.

Previous Close:

$0.2547

Open:

$0.258

24h Volume:

758.58K

Relative Volume:

0.53

Market Cap:

$12.01M

Revenue:

Net Income/Loss:

$-60.11M

P/E Ratio:

-0.0554

EPS:

-4.347

Net Cash Flow:

$-12.04M

1W Performance:

-23.36%

1M Performance:

-18.65%

6M Performance:

-77.91%

1Y Performance:

-68.63%

1-Day Range:

$0.24

$0.2759

1-Week Range:

$0.24

$0.31

52-Week Range:

$0.1772

$1.45

AEON Biopharma Inc. Stock (AEON) Company Profile

Name

AEON Biopharma Inc.

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(949) 354-6499

Address

5 Park Plaza, Suite 1750, Irvine

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

AEON's Discussions on Twitter

Compare AEON vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AEON AEON Biopharma Inc.	0.2408	9.63M	0	-60.11M	-12.04M	-4.347
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-23	Initiated	H.C. Wainwright	Buy

AEON Biopharma Inc. Stock (AEON) Latest News

Aug 21, 2026

Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo

Aug 19, 2026

AEON Flat on BOTOX Developments - Baystreet.ca

Aug 19, 2026

META_TITLE_QUOTE - Yahoo Finance

Aug 19, 2026

AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times

Aug 19, 2026

Aug 17, 2026

AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn

Aug 17, 2026

H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com

Aug 17, 2026

H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK

Aug 17, 2026

Aug 16, 2026

AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn

Aug 16, 2026

Aug 15, 2026

AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn

Aug 15, 2026

Aug 14, 2026

H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo

Aug 14, 2026

Aug 12, 2026

AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade

Aug 12, 2026

AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks

Aug 12, 2026

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 12, 2026

AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView

Aug 12, 2026

AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026

AEON BIOPHARMA INC Q2 EBIT USD -5.919 MILLION - Moomoo

Aug 12, 2026

Aug 07, 2026